n,n-dimethyltryptamine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazylewicz, M; Chorąży, M; Collins, F; Czarnowska, A; Gudowska-Sawczuk, M; Kapica-Topczewska, K; Kochanowicz, J; Kulczyńska-Przybik, A; Kulikowska, J; Kułakowska, A; Mroczko, B | 1 |
1 other study(ies) available for n,n-dimethyltryptamine and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies.
Topics: Antibodies, Viral; COVID-19; Dimethyl Fumarate; Glatiramer Acetate; Humans; Immunoglobulin A; Immunoglobulin G; Interferon-beta; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; N,N-Dimethyltryptamine; SARS-CoV-2 | 2023 |